Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
17.95Enterprise Value over EBITDA
VS
Market
Sector
Industry
History
$ 5.49Close
$ 1.36 - $ 5.68 52-Week Range
Ticker Information
Ticker
NEPHCompany Name
NEPHROS INCSector
HealthcareIndustry
Medical Instruments & SuppliesExchange
NASDAQNEPHROS INC - Enterprise Value over EBITDA Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NEPH - EV/EBITDA Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | Enterprise Value | Enterprise Value over EBITDA |
|---|---|---|---|
| 6/30/2025 | $ 1.49M | $ 26.8M | 17.95 |
| 3/31/2025 | $ 959K | $ 19.93M | 20.78 |
| 12/31/2024 | $ 227K | $ 13.76M | 60.63 |
| 9/30/2024 | $ -774K | $ 15.69M | 0 |
| 6/30/2024 | $ -1.12M | $ 21.01M | 0 |
| 3/31/2024 | $ -1.24M | $ 21.43M | 0 |
| 12/31/2023 | $ -1.36M | $ 20.41M | 0 |
| 9/30/2023 | $ -1.62M | $ 17.2M | 0 |
| 6/30/2023 | $ -4.62M | $ 11.48M | 0 |
| 3/31/2023 | $ -5.33M | $ 12.4M | 0 |
Key Performance Insights, Last 5 Years
- NEPHROS INC's latest trailing twelve months (TTM) EV/EBITDA stands at 0.
- Over the past 5 years, NEPHROS INC's average EV/EBITDA has been 33.12.
- The median EV/EBITDA for NEPHROS INC during this period was 20.78
- NEPHROS INC reached its highest EV/EBITDA over the past 5 years at 60.63.
- The lowest EV/EBITDA recorded by NEPHROS INC in the same timeframe 17.95
Similar metrics to EV/EBITDA:
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value - [Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].
- Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) - [Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
Definition of Enterprise Value over EBITDA
[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].EV / EBITDA
(=) EV/EBITDA EV/EBITDA for NEPHROS INC is calculated as follows: EV [ $ 58.71M ] / EBITDA [ $ -4.02M ]
(=) EV/EBITDA [ 0 ] NEPH - Enterprise Value over EBITDA, Last 5 years
17.95
Minimum
Jun 30, 2025
60.63
Maximum
Dec 31, 2024
33.12
Average
20.78
Median
EV/EBITDA Benchmark AnalysisMarket
The chart above depicts the distribution of EV/EBITDA for companies in the Total Stock Market. The average EV/EBITDA of the companies is 13.49 with a standard deviation of 7.66.
The following table provides additional summary stats:
EV/EBITDA in the Market:
| filtered constituents | 2.44K |
|---|---|
| min | 0.01 |
| max | 40.82 |
| average | 13.49 |
| median | 11.75 |
| std | 7.66 |